Clinical Trial Search

Primary: Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1). — 0.225; 0.400; 0.108; 0.170 Liters — p=<0.0001

Primary: Percentage of Participants Who Have Either an Asthma Control Test (ACT) Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Week 24. — 56; 71…

Primary: Pain as Assessed by Visual Analogue Scale (VAS) — 6.0; 5.9; 5.4; 5.3 units on a scale

Primary: Number of Subjects With rSBA-MenA, rSBA-MenC, rSBA-MenW-135 and rSBA-MenY Titers ≥ the Cut-off. — 193; 180; 191; 178 Participants

Primary: Percentage of Calcium Removal Out of Lumen Gain as Assessed by IVUS — 25.0; 0.0 percentage of lumen gain — p=0.0220

Primary: Number of Participants With Complete Healing of Ulcer During the Observation Period — 9; 5; 4 participants

Primary: Proportion of the Subjects With at Least 10mm Difference in VAS Pain Scale Scores Within the Subject (VAS of the Control Device - VAS of the Test Device) Immediately…

Primary: Number of Participants With >15 ETDRS Letter Loss at Month 3 — 0 Participants

Primary: Proportion of the Subjects With at Least 10mm Difference in VAS Pain Scale Scores Within the Subject (VAS of the Control Medical Device - VAS of the Test Medical Device)…

Primary: Response Rate (Complete and Partial Response) — 7 Participants

Primary: Percentage of Subjects With Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibody Concentrations Greater Than or Equal to (≥) the Cut-off Value — 100; 100; 98.6…

Primary: Number of Participants Smoking Abstinent in Past 7 Days — 16; 13 participants — p=.606

Primary: Cycles With Hematologic Toxicities — 11; 14; 6; 0 Cycles

Primary: Change From Baseline In The Modified Neuropathy Impairment Score (mNIS) +7 Composite Score at Week 66 — 4.16; 23.89 Scores on a Scale — p=0.00000004

Primary: Change in 400 Meter Gait Walk Speed — 0.01; -0.02 meters/second